Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Revenue

In the year 2025, Crescita Therapeutics had annual revenue of 21.12M CAD with 7.85% growth. Crescita Therapeutics had revenue of 5.96M in the quarter ending December 31, 2025, a decrease of -13.72%.

• Revenue: 21.12M
• Revenue Growth: +7.85%
• P/S Ratio: 0.66
• Revenue / Employee: n/a
• Employees: 62
• Market Cap: 13.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	21.12M	1.54M	7.85%
Dec 31, 2024	19.58M	2.06M	11.75%
Dec 31, 2023	17.52M	-6.00M	-25.52%
Dec 31, 2022	23.53M	6.76M	40.29%
Dec 31, 2021	16.77M	1.13M	7.22%
Dec 31, 2020	15.64M	-6.70M	-29.98%
Dec 31, 2019	22.34M	5.71M	34.33%
Dec 31, 2018	16.63M	4.61M	38.41%
Dec 31, 2017	12.01M	8.51M	242.87%
Dec 31, 2016	3.50M	3.28M	1,436.84%
Dec 31, 2015	228.00K	-602.00K	-72.53%
Dec 31, 2014	830.00K	-	-